Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Intangibles (2018 - 2020)

Historic Change in Intangibles for Collegium Pharmaceutical (COLL) over the last 2 years, with Q2 2020 value amounting to $1.4 million.

  • Collegium Pharmaceutical's Change in Intangibles changed N/A to $1.4 million in Q2 2020 from the same period last year, while for Dec 2020 it was $368.2 million, marking a year-over-year change of. This contributed to the annual value of $368.2 million for FY2020, which is N/A changed from last year.
  • As of Q2 2020, Collegium Pharmaceutical's Change in Intangibles stood at $1.4 million.
  • Collegium Pharmaceutical's 5-year Change in Intangibles high stood at $366.8 million for Q1 2020, and its period low was $116000.0 during Q2 2018.